DSM and Firmenich have completed their “merger of equals,” creating a robust business platform to “reinvent, manufacture and combine vital nutrients, flavours and fragrances.” The Swiss-Dutch group has a combined revenue of around EUR 12 bn.
DSM-Firmenich will continue to enhance its key products like vitamins, minerals, omega 3s and “anything that supports nutrition.” The company will also combine its expertise to create new progressive products.
As of 1 September 2023, the existing leadership structure will be changed, with co-CEO Dimitri de Vreeze taking over as CEO and Ralf Schmeitz joining the company as CFO. Current co-CEO Geraldine Matchett will step down. “With the merger now a reality, we have together determined that the dual leadership that has served DSM so well during a period of significant change is no longer needed for DSM-Firmenich going forward,” comments Thomas Leysen, Chairman of DSM-Firmenich.